RGEN
REPLIGEN CORP
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$179.95
+0.94%Margins
Gross margin
51.1%
EBITDA margin
15.6%
EBIT margin
2.3%
Net margin
-1.5%
FCF margin
13.2%
-0.6%
Return on equity
-0.4%
Return on assets
0.7%
Return on invested capital
0.27x
Asset turnover
$129.9M
Cash from operations
$14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026